Scope
The IAP–NNF chapter describes therapeutic hypothermia for selected neonates with moderate-to-severe hypoxic–ischemic encephalopathy. Its India-specific post-HELIX caveat is central: cooling should be considered only in highly selected infants within appropriately equipped tertiary neonatal intensive care. Eligibility assessment, safe temperature control, intensive monitoring and structured follow-up are integral to treatment, rather than cooling being an isolated procedure.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Restrict cooling to eligible infants and capable units
- In India after HELIX, consider therapeutic hypothermia only in highly selected infants and in Level III/IV neonatal intensive-care units. The service requires servo-controlled equipment, dedicated nursing and continuous neonatologist availability. [1]
- The chapter strongly recommends initiation within 6 hours of birth for eligible infants at ≥36 weeks with moderate-to-severe encephalopathy; evidence certainty is moderate. Do not routinely initiate cooling after that window. [1]
- Screen depressed term and near-term infants promptly for biochemical and neurological eligibility. The eligibility box requires perinatal-asphyxia evidence plus moderate-to-severe encephalopathy and exclusion of major contraindications; use the unit protocol derived from major trials. [1]
- Do not offer cooling where safe monitoring and intensive-care support are unavailable. Exclusions in the chapter include major congenital malformation, severe growth restriction, severe coagulopathy and serious head trauma or intracranial hemorrhage. [1]
- Use serial neurological assessment and consider alternative causes of encephalopathy. Mild encephalopathy has uncertain routine-cooling benefit; sepsis, metabolic abnormalities and intracranial bleeding need cause-specific evaluation and treatment. [1]
Stabilise, refer and counsel without losing time
- Arrange urgent transfer to a cooling-capable centre without delaying stabilization. Until eligibility is confirmed, maintain normothermia and avoid fever; active or passive cooling requires explicit receiving-team direction and temperature monitoring. [1]
- Maintain airway, breathing and circulation, with ventilation when needed. Obtain vascular access and baseline glucose, blood gas, electrolytes, blood count, coagulation, renal and liver testing; consider cranial ultrasound. [1]
- Before initiation, counsel parents about the indication, potential benefits and complications, intensive monitoring, seizures, imaging, uncertainty of outcomes and developmental follow-up. Document informed written consent under unit policy. [1]
Use controlled cooling and reliable monitoring
- The chapter strongly recommends whole-body cooling to a core temperature of 33.5 ± 0.5°C for 72 hours, followed by slow rewarming; the stated evidence certainty is high. Prefer a servo-controlled device with continuous core-temperature monitoring. [1]
- Unmonitored passive cooling or rewarming risks overshoot and temperature fluctuations and should be discouraged. Nonservo methods are not recommended for maintenance; only a transient transport exception is described when servo control is unavailable, with very frequent temperature checks and direct tertiary-team guidance. [1]
- Monitor blood gases, glucose, electrolytes, coagulation and cardiorespiratory variables throughout cooling and rewarming. EEG or amplitude-integrated EEG is desirable when available, but the chapter does not make it mandatory for cooling. [1]
- Check probe position and fixation at every nursing shift, respond to alarms by examining the baby and equipment, and keep an independent thermometer for cross-checking. Inspect contact areas for pressure injury or fat necrosis and follow device-calibration procedures. [1]
Treat complications while reassessing treatment safety
- Treat clinical and, where detectable, electrographic seizures when present. Do not routinely give prophylactic antiseizure medication; this is a conditional recommendation supported by low-certainty evidence. [1]
- Monitor glucose, electrolytes, renal function and urine output closely and correct abnormalities. Assess volume status before treating hypotension, and monitor for arrhythmia and persistent pulmonary hypertension. [1]
- Use comfort measures and judicious analgesia or sedation when needed; routine sedation and paralysis are not necessary and can interfere with neurological assessment. Following severe hypoxia, wait for hemodynamic stability and absence of active seizures before assessing feeding readiness. [1]
- Consider discontinuing cooling early for refractory hypotension despite maximal support, life-threatening arrhythmia, severe coagulopathy or uncontrolled major bleeding, or equipment failure that prevents safe temperature control. [1]
Rewarm slowly and arrange follow-up
- After 72 hours, use controlled rewarming at 0.25–0.5°C/hour toward 36.5°C over 6–12 hours. Increase monitoring during this phase because seizures, hypotension and electrolyte shifts may recur; continue postcooling monitoring after temperature stabilizes. [1]
- Plan structured neurodevelopmental follow-up and explain its importance to parents. The chapter also calls for documenting cooling timing, eligibility and admission temperature in every treated neonate. [1]
Limitations and use
- This summary does not reproduce a complete eligibility checklist: the source prints a potentially ambiguous base-excess inequality. Confirm biochemical criteria in the neonatal unit’s validated protocol rather than using this summary to determine eligibility.
- The chapter does not establish routine cooling for mild encephalopathy, late presentation or preterm infants outside its stated eligibility.
- Drug-loading regimens, fluid prescriptions, probe-placement technique and the complete imaging and follow-up schedule are not reproduced; these require neonatal specialist protocols.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Therapeutic Hypothermia in Hypoxic–Ischemic Encephalopathy in Neonates
Selected recommendation material consulted
Publication details
- Issuing organisation
- IAP / NNF
- Resource type
- Quick-reference guideline · House clinical summary
- Source setting
- India
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.